Dicationic diarylfurans as anti-Pneumocystis carinii agents. 1995

D W Boykin, and A Kumar, and J Spychala, and M Zhou, and R J Lombardy, and W D Wilson, and C C Dykstra, and S K Jones, and J E Hall, and R R Tidwell
Department of Chemistry, Georgia State University, Atlanta 30303.

Seven dicationic 2,5-diarylfurans have been synthesized, and their interactions with poly(dA-dT) and the duplex oligomer d(CGCCAATTCGCG)2 were evaluated by Tm measurements. The inhibition of topoisomerase II isolated from Giardia lamblia, the inhibition of growth of G. lamblia in cell culture by these furans, and the effectiveness of these compounds against Pneumocystis carinii in the immunosuppressed rat model have been assessed. Strong binding affinities to poly(dA-dT) and to the oligomer were observed for the dicationic furans, and the interaction strength is directly correlated to the biological activity of the compounds. An X-ray structure for the complex of the dicationic amidine derivative, 2,5-bis(4-guanylphenyl)furan (1), with the oligomer demonstrates the snug fit of these compounds with the AATT minor-groove binding site and hydrogen bonds to AT base pairs at the floor of the minor groove. The stronger DNA binding molecules are the most effective inhibitors of topoisomerase II and G. lamblia in cell culture, and there is a correlation for both DNA interaction and topoisomerase II inhibition with the biological activity of these compounds against G. lamblia. Compound 1 is the most effective against P. carinii, it is more active and less toxic than pentamidine on intravenous administration and it is also effective by oral dosage. The results presented here suggest a model for the biological action of these compounds in which the dication first binds in the minor groove of DNA and forms a complex that results in the inhibition of the microbial topoisomerase II enzyme.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009690 Nucleic Acid Conformation The spatial arrangement of the atoms of a nucleic acid or polynucleotide that results in its characteristic 3-dimensional shape. DNA Conformation,RNA Conformation,Conformation, DNA,Conformation, Nucleic Acid,Conformation, RNA,Conformations, DNA,Conformations, Nucleic Acid,Conformations, RNA,DNA Conformations,Nucleic Acid Conformations,RNA Conformations
D009841 Oligonucleotides Polymers made up of a few (2-20) nucleotides. In molecular genetics, they refer to a short sequence synthesized to match a region where a mutation is known to occur, and then used as a probe (OLIGONUCLEOTIDE PROBES). (Dorland, 28th ed) Oligonucleotide
D011010 Pneumocystis A genus of ascomycetous FUNGI, family Pneumocystidaceae, order Pneumocystidales. It includes various host-specific species causing PNEUMOCYSTIS PNEUMONIA in humans and other MAMMALS. Pneumocysti
D011067 Poly dA-dT Polydeoxyribonucleotides made up of deoxyadenine nucleotides and thymine nucleotides. Present in DNA preparations isolated from crab species. Synthetic preparations have been used extensively in the study of DNA. Poly(Deoxyadenylate-Thymidylate),Polydeoxyadenine Nucleotides-Polythymine Nucleotides,Poly dA dT,Poly(dA-dT),d(A(5)T(5))2,Nucleotides, Polydeoxyadenine Nucleotides-Polythymine,Nucleotides-Polythymine Nucleotides, Polydeoxyadenine,Polydeoxyadenine Nucleotides Polythymine Nucleotides,dA dT, Poly,dA-dT, Poly,dT, Poly dA
D002412 Cations Positively charged atoms, radicals or groups of atoms which travel to the cathode or negative pole during electrolysis. Cation
D005663 Furans Compounds with a 5-membered ring of four carbons and an oxygen. They are aromatic heterocycles. The reduced form is tetrahydrofuran. Tetrahydrofurans
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics

Related Publications

D W Boykin, and A Kumar, and J Spychala, and M Zhou, and R J Lombardy, and W D Wilson, and C C Dykstra, and S K Jones, and J E Hall, and R R Tidwell
June 1999, Journal of medicinal chemistry,
D W Boykin, and A Kumar, and J Spychala, and M Zhou, and R J Lombardy, and W D Wilson, and C C Dykstra, and S K Jones, and J E Hall, and R R Tidwell
May 1994, Antimicrobial agents and chemotherapy,
D W Boykin, and A Kumar, and J Spychala, and M Zhou, and R J Lombardy, and W D Wilson, and C C Dykstra, and S K Jones, and J E Hall, and R R Tidwell
January 1991, The Journal of protozoology,
D W Boykin, and A Kumar, and J Spychala, and M Zhou, and R J Lombardy, and W D Wilson, and C C Dykstra, and S K Jones, and J E Hall, and R R Tidwell
October 2001, Bioorganic & medicinal chemistry letters,
D W Boykin, and A Kumar, and J Spychala, and M Zhou, and R J Lombardy, and W D Wilson, and C C Dykstra, and S K Jones, and J E Hall, and R R Tidwell
January 1999, European journal of medicinal chemistry,
D W Boykin, and A Kumar, and J Spychala, and M Zhou, and R J Lombardy, and W D Wilson, and C C Dykstra, and S K Jones, and J E Hall, and R R Tidwell
November 1983, Antimicrobial agents and chemotherapy,
D W Boykin, and A Kumar, and J Spychala, and M Zhou, and R J Lombardy, and W D Wilson, and C C Dykstra, and S K Jones, and J E Hall, and R R Tidwell
February 1997, Antimicrobial agents and chemotherapy,
D W Boykin, and A Kumar, and J Spychala, and M Zhou, and R J Lombardy, and W D Wilson, and C C Dykstra, and S K Jones, and J E Hall, and R R Tidwell
June 2010, Molecules (Basel, Switzerland),
D W Boykin, and A Kumar, and J Spychala, and M Zhou, and R J Lombardy, and W D Wilson, and C C Dykstra, and S K Jones, and J E Hall, and R R Tidwell
January 1993, Bioorganic & medicinal chemistry letters,
D W Boykin, and A Kumar, and J Spychala, and M Zhou, and R J Lombardy, and W D Wilson, and C C Dykstra, and S K Jones, and J E Hall, and R R Tidwell
May 2001, Journal of medicinal chemistry,
Copied contents to your clipboard!